PL2405893T3 - Kompozycja na bazie oleju zawierająca przeciwpierwotniakowe triazyny i antyhelmintyczne cyklodepsypeptydy - Google Patents

Kompozycja na bazie oleju zawierająca przeciwpierwotniakowe triazyny i antyhelmintyczne cyklodepsypeptydy

Info

Publication number
PL2405893T3
PL2405893T3 PL10707228T PL10707228T PL2405893T3 PL 2405893 T3 PL2405893 T3 PL 2405893T3 PL 10707228 T PL10707228 T PL 10707228T PL 10707228 T PL10707228 T PL 10707228T PL 2405893 T3 PL2405893 T3 PL 2405893T3
Authority
PL
Poland
Prior art keywords
trazines
cyclodepsipeptides
anthelminthic
protozoal
oil
Prior art date
Application number
PL10707228T
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Achim Harder
Thomas Bach
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL2405893T3 publication Critical patent/PL2405893T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
PL10707228T 2009-03-10 2010-03-05 Kompozycja na bazie oleju zawierająca przeciwpierwotniakowe triazyny i antyhelmintyczne cyklodepsypeptydy PL2405893T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009012423A DE102009012423A1 (de) 2009-03-10 2009-03-10 Zubereitung auf Ölbasis
PCT/EP2010/001396 WO2010102762A1 (de) 2009-03-10 2010-03-05 Zubereitung auf ölbasis enthaltend anti-protozoische triazine und anthelmintische cyclodepsipeptide
EP10707228.2A EP2405893B1 (de) 2009-03-10 2010-03-05 Zubereitung auf Ölbasis enthaltend anti-protozoische Triazine und anthelmintische Cyclodepsipeptide

Publications (1)

Publication Number Publication Date
PL2405893T3 true PL2405893T3 (pl) 2015-10-30

Family

ID=42105958

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10707228T PL2405893T3 (pl) 2009-03-10 2010-03-05 Kompozycja na bazie oleju zawierająca przeciwpierwotniakowe triazyny i antyhelmintyczne cyklodepsypeptydy

Country Status (21)

Country Link
US (1) US20120141546A1 (pl)
EP (1) EP2405893B1 (pl)
JP (2) JP5845092B2 (pl)
KR (1) KR101779618B1 (pl)
CN (2) CN105749248A (pl)
AR (1) AR075629A1 (pl)
AU (1) AU2010223539B2 (pl)
BR (1) BRPI1009434A2 (pl)
CA (1) CA2754623C (pl)
DE (1) DE102009012423A1 (pl)
DK (1) DK2405893T3 (pl)
ES (1) ES2542552T3 (pl)
HR (1) HRP20150780T1 (pl)
MX (1) MX2011009113A (pl)
NZ (1) NZ595050A (pl)
PL (1) PL2405893T3 (pl)
PT (1) PT2405893E (pl)
SI (1) SI2405893T1 (pl)
TW (1) TW201043234A (pl)
WO (1) WO2010102762A1 (pl)
ZA (1) ZA201106349B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108187028A (zh) * 2011-12-21 2018-06-22 拜耳知识产权有限责任公司 包含无定形艾默德斯的制剂
CN110292561A (zh) * 2019-07-12 2019-10-01 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种具有抗球虫作用的口服药物溶液配方及制备
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) * 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
JPH0570366A (ja) * 1991-03-08 1993-03-23 Meiji Seika Kaisha Ltd 薬用組成物
CA2132199C (en) 1992-03-17 2000-01-18 Hitoshi Nishiyama Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
CN1073560C (zh) 1993-02-19 2001-10-24 明治制果株式会社 环缩酚酸肽pf1022衍生物
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
US5646244A (en) 1993-09-06 1997-07-08 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4342907A1 (de) 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4401389A1 (de) 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4412492A1 (de) 1994-04-12 1995-10-19 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
CN1071323C (zh) 1995-06-30 2001-09-19 藤泽药品工业株式会社 缩肽衍生物或其盐的制造方法
NZ318515A (en) 1995-09-22 2000-05-26 Bayer Ag Cyclodepsipeptide PF1022 derivatives and compositions thereof
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
DE19545639A1 (de) 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
AU6229898A (en) 1997-02-19 1998-09-09 Bayer Aktiengesellschaft Derivatives of cyclodepsipeptide, pf1022 substance
DE19713626A1 (de) 1997-04-02 1998-10-08 Bayer Ag Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung
CN1076349C (zh) 1997-06-04 2001-12-19 拜尔公司 去氧环缩肽及其防治体内寄生虫的用途
DE19811559A1 (de) 1998-03-17 1999-09-23 Bayer Ag Cyclooctadepsipeptide
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
DE19828047A1 (de) 1998-06-24 1999-12-30 Bayer Ag Substituierte Cyclooctadepsipeptide
DE19840320A1 (de) 1998-09-04 2000-03-09 Bayer Ag Aza-Cyclodepsipeptide
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
NZ512476A (en) * 1998-12-22 2003-08-29 Bayer Ag Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
DE19962147A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10040174A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE10359798A1 (de) * 2003-12-19 2005-07-21 Bayer Healthcare Ag Cyclohexadepsipeptide zur Bekämpfung von Endoparasiten und ein Verfahren zu ihrer Herstellung
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102005000746A1 (de) * 2005-01-05 2006-07-13 Bayer Healthcare Ag Bekämpfung der Histomoniasis
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
EP2059231A1 (en) * 2006-08-30 2009-05-20 Intervet International BV Pharmaceutical compositions comprising cefquinome
PL3088384T3 (pl) * 2007-05-15 2019-06-28 Merial, Inc. Związki aryloazol-2-ilo-cyjanoetyloaminowe, sposób ich wytwarzania oraz sposób ich stosowania
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung

Also Published As

Publication number Publication date
JP2015212296A (ja) 2015-11-26
TW201043234A (en) 2010-12-16
AU2010223539A1 (en) 2011-09-22
NZ595050A (en) 2013-11-29
CN105749248A (zh) 2016-07-13
US20120141546A1 (en) 2012-06-07
PT2405893E (pt) 2015-09-01
ZA201106349B (en) 2012-11-28
AU2010223539B2 (en) 2015-06-11
WO2010102762A1 (de) 2010-09-16
ES2542552T3 (es) 2015-08-06
DE102009012423A1 (de) 2010-09-16
HRP20150780T1 (hr) 2015-08-28
KR20110126731A (ko) 2011-11-23
DK2405893T3 (en) 2015-07-27
CN102348454A (zh) 2012-02-08
SI2405893T1 (sl) 2015-08-31
CA2754623A1 (en) 2010-09-16
EP2405893A1 (de) 2012-01-18
MX2011009113A (es) 2011-09-26
CA2754623C (en) 2017-04-18
JP5845092B2 (ja) 2016-01-20
AR075629A1 (es) 2011-04-20
KR101779618B1 (ko) 2017-09-18
BRPI1009434A2 (pt) 2016-03-01
EP2405893B1 (de) 2015-04-22
JP2012520244A (ja) 2012-09-06

Similar Documents

Publication Publication Date Title
AP3106A (en) Antiparisitic dihydroazole compounds and compositions comprising same
IL217280A0 (en) Compositions comprising combinations of phyto-cannabinoids and uses thereof
IL241098B (en) Antimicrobial preparations and methods of using them
ZA201003696B (en) Compositions and devices
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
IL211204A0 (en) Mucoadherents compositions and their use
IL219470A0 (en) Compositions containing fractalknie-binding proteins and uses thereof
TWI367763B (en) Compositions and devices
IL219552A (en) Synergistic antiviral drug and its use
ZA201200079B (en) Pharmaceutical compositions and solid forms
EP2421923A4 (en) INK COMPOSITIONS AND USE
GB0902429D0 (en) Compositions and their use
EP2490536A4 (en) COMPOSITION AND METHOD
GB0902173D0 (en) Compounds and their use
PT2405893E (pt) Preparação à base de óleo contendo triazinas antiprotozoários e ciclodepsipeptídeos anti-helmínticos
GB0922510D0 (en) Compound and use
GB0902648D0 (en) Pharmaceutical compounds and compositions
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
EP2381950A4 (en) COMPOSITIONS AND METHOD FOR THEIR USE
GB0900727D0 (en) Haemostatic agent and uses thereof
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0909792D0 (en) Composition and uses thereof
EP2488624A4 (en) STABILIZED SURFACTANT-OXIDANT COMPOSITIONS AND METHODS THEREOF
GB0902812D0 (en) Composition and use
GB0901899D0 (en) Compositions and uses